Depletion of HDAC3 or other HDACs suppresses expression of AR and its downstream target genes in prostate cancer cells, although the underlying mechanism remains poorly understood (Welsbie et al, 2009). The gene discussed is HDAC3; the disease is prostate carcinoma.